Other imaging modalities, including MRI and 2-deoxy-2-(18F)fluoro-D-glucose (18FDG)-positron emission tomography (PET), may also be valuable in the follow-up of thyroid cancer metastases, particularly in patients with elevated Tg levels and normal radioiodine WBS (21). This evidence concerns the gene TG and thyroid cancer.